Literature DB >> 31187534

Cutaneous lymphomas-An update 2019.

Werner Kempf1,2, Anne-Katrin Zimmermann1, Christina Mitteldorf3.   

Abstract

Primary cutaneous lymphomas (CL) are the second most common form of extranodal lymphomas. Cutaneous T-cell lymphomas represent the majority. They are classified according to the WHO classification 2017 and the updated WHO-EORTC 2018 published in the fourth edition of the WHO classification for Skin Tumors monograph. Primary cutaneous acral CD8+ T-cell lymphoma and EBV-positive mucocutaneous ulcer have been listed as new provisional entities. Moreover, the histological and genetic spectrum of lymphomatoid papulosis has been expanded. Recently, prognostic subtypes were delineated for some entities and subtypes of CL such as folliculotropic mycosis fungoides and marginal zone lymphoma. Since CL show overlapping histological features, clinico-pathological correlation is of outmost importance for the diagnosis. Recent studies revealed new biomarkers and genetic alterations underlying the pathogenesis of CL. Moreover, targeted therapies have widened the treatment options particularly for aggressive lymphomas.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  B cell; T-cell; classification; cutaneous; dermatopathology; diagnosis; lymphoma; skin

Mesh:

Year:  2019        PMID: 31187534     DOI: 10.1002/hon.2584

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  7 in total

Review 1.  Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas.

Authors:  Amanda Krenitsky; Skylar Klager; Leigh Hatch; Carlos Sarriera-Lazaro; Pei Ling Chen; Lucia Seminario-Vidal
Journal:  Am J Clin Dermatol       Date:  2022-07-19       Impact factor: 6.233

2.  Total skin electron beam therapy for primary cutaneous T-cell lymphomas: clinical characteristics and outcomes in a Mexican reference center.

Authors:  Ch Flores-Balcázar; D M Urías-Arce; Y Charli-Joseph; M A De León-Alfaro; S I Pérez-Álvarez; R Ramos-Prudencio
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-27

3.  Targeting Cutaneous T-Cell Lymphoma Cells by Ingenol Mebutate (PEP005) Correlates with PKCδ Activation, ROS Induction as Well as Downregulation of XIAP and c-FLIP.

Authors:  Uly Sumarni; Ulrich Reidel; Jürgen Eberle
Journal:  Cells       Date:  2021-04-23       Impact factor: 6.600

Review 4.  Primary Cutaneous B-Cell Lymphomas: An Update.

Authors:  Paola Vitiello; Antonello Sica; Andrea Ronchi; Stefano Caccavale; Renato Franco; Giuseppe Argenziano
Journal:  Front Oncol       Date:  2020-05-27       Impact factor: 6.244

5.  Laying the groundwork for the Biobank of Rare Malignant Neoplasms at the service of the Hellenic Network of Precision Medicine on Cancer.

Authors:  Dimitrios S Kanakoglou; Andromachi Pampalou; Dimitrios M Vrachnos; Eleni A Karatrasoglou; Dionysia N Zouki; Emmanouil Dimonitsas; Alexia Klonou; Georgia Kokla; Varvara Theologi; Errieta Christofidou; Stratigoula Sakellariou; Eleftheria Lakiotaki; Christina Piperi; Penelope Korkolopoulou
Journal:  Int J Oncol       Date:  2022-02-16       Impact factor: 5.650

Review 6.  The Skin Microbiome and Influencing Elements in Cutaneous T-Cell Lymphomas.

Authors:  Marion Jost; Ulrike Wehkamp
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

7.  Primary cutaneous lymphoma and risk for severe COVID-19: a prospective study of 48 cases in Morocco.

Authors:  H Kerrouch; M Khalidi; R Frikh; N Hjira; M Boui
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-03-17       Impact factor: 9.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.